*Some Market data delayed by 15 mins.

Connect Biopharma Holdings Limited Ordinary Shares

Symbol: CNTB (NASDAQ)
1.51 ▲ (8.27%) 0.115

Company Description:
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.

Key Stats
  • Today's Open: $1.39
  • Today's High: $1.53
  • Today's Low: $1.385
  • Today's Volume: 37.88K
  • Yesterday Close: $1.39
  • Yesterday High: $1.4987
  • Yesterday Low: $1.36
  • Yesterday Volume: 88.99K
  • Last Min Volume: 200
  • Last Min High: $1.505
  • Last Min Low: $1.505
  • Last Min VWAP: $1.505
Company Profile
  • Name: Connect Biopharma Holdings Limited Ordinary Shares
  • Website: https://www.connectbiopharm.com
  • Listed Date: 2025-09-03
  • Location: SAN DIEGO, CA
  • Market Status: Active
  • CIK Number: 0001835268
  • SIC Code: 2834
  • SIC description: PHARMACEUTICAL PREPARATIONS
  • Market Cap: $83.04M
  • Round Lot: 100
  • Outstanding Shares: 55.73M
  • Asset Type: CS
RECENT FILINGS FOR CNTB
Filing Date Filing Type Format
2025-10-01 144 View
2025-09-16 8-K View
2025-09-12 EFFECT View
2025-09-10 POS AM View
2025-08-13 10-Q View
2025-08-13 8-K View
2025-07-22 8-K View
2025-07-21 8-K View
2025-07-21 SCHEDULE 13D/A View
2025-07-18 F-6 POS View
2025-07-17 8-K View
2025-07-09 8-K View
2025-06-26 EFFECT View
2025-06-24 CORRESP View
2025-06-12 UPLOAD View
2025-06-11 144 View
2025-06-10 S-8 View
2025-06-10 F-3 View
2025-05-15 10-Q View
2025-05-15 8-K View
Latest News on CNTB

 

NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money. Copyright© 2024, 247MarketNews inc.